Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.
Condition: TOURETTE SYNDROME Interventions: Drug: TEV-50717; Drug: Placebo Sponsor: Teva Branded Pharmaceutical Products, R&D Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials